Reaction
Hyperparathyroidism Primary reporting signals
As of the last recalculation, Hyperparathyroidism Primary appears in 362 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is LITHIUM CARBONATE (PRR 131.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lithium Carbonate | 35 | 131.1 | 131.3 |
| Cinacalcet Hydrochloride | 18 | 23.3 | 23.3 |
| Romosozumab-Aqqg | 3 | 12.8 | 12.8 |